Drug & medication recalls Moderate risk

Macleods Pharma Usa Inc recalls Pioglitazone Hydrochloride Tablets USP 15 mg, 30 count bottles, Rx only, Manufactured for: Macleods Pharma USA, Inc., P…

Recall date
September 23, 2019
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Recall number
D-0140-2020
FDA classification
Class II
Brand / firm
Macleods Pharma Usa Inc
Sold / distributed
Product was shipped to 8 distributors who may have further distributed the product.

Why it was recalled

Superpotent

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Pioglitazone Hydrochloride Tablets USP 15 mg, 30 count bottles, Rx only, Manufactured for: Macleods Pharma USA, Inc., Plainsboro, NJ, Manufactured by: Macleods Pharmaceuticals Ltd., Baddi, Himachal Pradesh, India NDC 33342-054-07

Get recall alerts

Free email alert whenever Macleods Pharma Usa Inc has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Macleods Pharma Usa Inc